Metabolic health of muscle / sarcopenia (age-related muscle loss) Musculoskeletal Diseases Muscle wasting and atrophy, not elsewhere classified
Conditions
Interventions
Each participant was randomly assigned to one of four groups. Each participant ingested one of four doses (0, 10, 20 or 40g) of whey protein after the exercise.
Sponsors
GlaxoSmithKline Nutritional Healthcare (UK)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Male, aged 18-35 years 2. Healthy (no known metabolic disorder) 3. Experienced weight lifter for more than 6 months (at least 2 leg resistance training sessions per week)
Exclusion criteria
Exclusion criteria: Not simultaneously taking part in another scientific / clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Myofibrillar (contractile proteins) muscle protein synthesis | — |
Secondary
| Measure | Time frame |
|---|---|
| Amino acid concentrations | — |
Countries
United Kingdom
Outcome results
None listed